These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29675399)

  • 21. Unprimed, M1 and M2 Macrophages Differentially Interact with Porphyromonas gingivalis.
    Lam RS; O'Brien-Simpson NM; Holden JA; Lenzo JC; Fong SB; Reynolds EC
    PLoS One; 2016; 11(7):e0158629. PubMed ID: 27383471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HmuY is an important virulence factor for Porphyromonas gingivalis growth in the heme-limited host environment and infection of macrophages.
    Olczak T; Sosicka P; Olczak M
    Biochem Biophys Res Commun; 2015 Nov; 467(4):748-53. PubMed ID: 26482851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of
    Frey AM; Satur MJ; Phansopa C; Honma K; Urbanowicz PA; Spencer DIR; Pratten J; Bradshaw D; Sharma A; Stafford G
    Microbiology (Reading); 2019 Nov; 165(11):1181-1197. PubMed ID: 31517596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porphyromonas gingivalis-stimulated macrophage subsets exhibit differential induction and responsiveness to interleukin-10.
    Foey AD; Habil N; Al-Shaghdali K; Crean S
    Arch Oral Biol; 2017 Jan; 73():282-288. PubMed ID: 27816791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism and implications of CXCR4-mediated integrin activation by Porphyromonas gingivalis.
    Hajishengallis G; McIntosh ML; Nishiyama SI; Yoshimura F
    Mol Oral Microbiol; 2013 Aug; 28(4):239-49. PubMed ID: 23331495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sialylation of Porphyromonas gingivalis LPS and its effect on bacterial-host interactions.
    Zaric SS; Lappin MJ; Fulton CR; Lundy FT; Coulter WA; Irwin CR
    Innate Immun; 2017 Apr; 23(3):319-326. PubMed ID: 28205451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential capacity for complement receptor-mediated immune evasion by Porphyromonas gingivalis depending on the type of innate leukocyte.
    Hajishengallis G; Krauss JL; Jotwani R; Lambris JD
    Mol Oral Microbiol; 2017 Apr; 32(2):154-165. PubMed ID: 27081768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The recA gene in Porphyromonas gingivalis is expressed during infection of the murine host.
    Liu Y; Fletcher HM
    Oral Microbiol Immunol; 2001 Aug; 16(4):218-23. PubMed ID: 11442846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat Periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production.
    Wang HY; Lin L; Fu W; Yu HY; Yu N; Tan LS; Cheng JW; Pan YP
    BMC Complement Altern Med; 2017 Aug; 17(1):426. PubMed ID: 28851350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of cytokine production by Porphyromonas gingivalis in a macrophage and epithelial cell co-culture model.
    Bodet C; Chandad F; Grenier D
    Microbes Infect; 2005 Mar; 7(3):448-56. PubMed ID: 15811635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MIP From
    Shen Y; Xu J; Zhi S; Wu W; Chen Y; Zhang Q; Zhou Y; Deng Z; Li W
    Front Cell Infect Microbiol; 2022; 12():810865. PubMed ID: 35573783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver X receptors contribute to periodontal pathogen-elicited inflammation and oral bone loss.
    Huang N; Shaik-Dasthagirisaheb YB; LaValley MP; Gibson FC
    Mol Oral Microbiol; 2015 Dec; 30(6):438-50. PubMed ID: 25946408
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Makkawi H; Hoch S; Burns E; Hosur K; Hajishengallis G; Kirschning CJ; Nussbaum G
    Front Cell Infect Microbiol; 2017; 7():359. PubMed ID: 28848717
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes.
    Vernal R; León R; Silva A; van Winkelhoff AJ; Garcia-Sanz JA; Sanz M
    J Clin Periodontol; 2009 Oct; 36(10):823-9. PubMed ID: 19682172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sialidase inhibitor, DANA, reduces Porphyromonas gingivalis pathogenicity and exerts anti-inflammatory effects: An in vitro and in vivo experiment.
    Yu S; Fan X; Zheng S; Lin L; Liu J; Pan Y; Li C
    J Periodontol; 2021 Feb; 92(2):286-297. PubMed ID: 32609876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between miR-661, miR-1202, lncRNA-HOTAIR, lncRNA-GAS5 and MMP9 in differentiated M2-macrophages of patients with varicose veins.
    Biranvand AS; Khosravi M; Esfandiari G; Poursaleh A; Hosseini-Fard SR; Amirfarhangi A; Najafi M
    Int Angiol; 2018 Dec; 37(6):451-456. PubMed ID: 30558403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-499 enhances
    Wang C; Li X
    J Biosci; 2023; 48():. PubMed ID: 38047488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of B7-H1 receptor by bacterial cells fractions of Porphyromonas gingivalis on human oral epithelial cells: B7-H1 induction by Porphyromonas gingivalis fractions.
    Groeger S; Jarzina F; Mamat U; Meyle J
    Immunobiology; 2017 Feb; 222(2):137-147. PubMed ID: 28164807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration.
    d'Empaire G; Baer MT; Gibson FC
    Infect Immun; 2006 Nov; 74(11):6236-43. PubMed ID: 16940143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils.
    Castro SA; Collighan R; Lambert PA; Dias IH; Chauhan P; Bland CE; Milic I; Milward MR; Cooper PR; Devitt A
    Cell Death Dis; 2017 Mar; 8(3):e2644. PubMed ID: 28252646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.